All In Biotech

Free tool

FAERS Monitor: Fulvestrant

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 210326 or its brand name (Fulvestrant, Fulvestrant). Reports on generic versions are filed under their own applications.

Reports

17,216

Serious

15,760

92% of reports

Hospitalization

4,473

Death reported

2,840

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • malignant neoplasm progression2,842
  • fatigue1,865
  • neutropenia1,718
  • nausea1,598
  • metastases to bone1,493
  • death1,411
  • diarrhoea1,408
  • breast cancer metastatic1,259
  • metastases to liver1,226
  • neoplasm progression986
  • asthenia967
  • vomiting917
  • pain902
  • dyspnoea871
  • anaemia839

Reports by year received

View as table
YearReports
20042
200515
20069
20076
200820
20099
20108
201147
201240
201328
201435
2015120
2016254
2017483
2018699
20191,157
20202,013
20212,071
20222,058
20232,861
20241,970
20252,074
20261,237

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,036,943 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
breast cancer metastaticSignal1,259162.2153.2178,007
metastases to boneSignal1,493122.1116.1163,094
metastases to liverSignal1,22691.686.6102,184
neoplasm progressionSignal98635.633.532,269
malignant neoplasm progressionSignal2,84234.833.791,241
neutropeniaSignal1,71815.614.923,351
anaemiaSignal8395.45.03,013
astheniaSignal9673.13.01,437
fatigueSignal1,8652.92.82,456
diarrhoeaSignal1,4082.72.51,510
nauseaSignal1,5982.52.41,448
vomitingSignal9172.42.2752
deathSignal1,4112.01.9736
dyspnoea8711.91.8368
pain9021.81.7326

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.